Evaluating the Impact of Inadequate Meal Consumption on Insulin-Related Hypoglycemia in Hospitalized Patients.


Journal

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
ISSN: 1530-891X
Titre abrégé: Endocr Pract
Pays: United States
ID NLM: 9607439

Informations de publication

Date de publication:
May 2021
Historique:
received: 04 06 2020
revised: 09 09 2020
accepted: 06 11 2020
entrez: 3 5 2021
pubmed: 4 5 2021
medline: 5 5 2021
Statut: ppublish

Résumé

Meal intake is sometimes reduced in hospitalized patients. Meal-time insulin administration can cause hypoglycemia when a meal is not consumed. Inpatient providers may avoid ordering meal-time insulin due to hypoglycemia concerns, which can result in hyperglycemia. The frequency of reduced meal intake in hospitalized patients remains inadequately determined. This quality improvement project evaluates the percentage of meals consumed by hospitalized patients with insulin orders and the resulting risk of postmeal hypoglycemia (blood glucose [BG] <70 mg/dL, <3.9 mmol/L). This was a retrospective quality improvement project evaluating patients with any subcutaneous insulin orders hospitalized at a regional academic medical center between 2015 and 2017. BG, laboratory values, point of care, insulin administration, diet orders, and percentage of meal consumed documented by registered nurses were abstracted from electronic health records. Meal consumption ≥50% was observed for 85% of meals with insulin orders, and bedside registered nurses were accurate at estimating this percentage. Age ≥65 years was a risk factor for reduced meal consumption (21% of meals 0%-49% consumed, P < .05 vs age < 65 years [12%]). Receiving meal-time insulin and then consuming only 0% to 49% of a meal (defined here as a mismatch) was not rare (6% of meals) and increased postmeal hypoglycemia risk. However, the attributable risk of postmeal hypoglycemia due to this mismatch was low (4 events per 1000) in patients with premeal BG between 70 and 180 mg/dL. This project demonstrates that hospitalized patients treated with subcutaneous insulin have a low attributable risk of postmeal hypoglycemia related to inadequate meal intake.

Identifiants

pubmed: 33934753
pii: S1530-891X(20)48374-0
doi: 10.1016/j.eprac.2020.11.007
pii:
doi:

Substances chimiques

Blood Glucose 0
Hypoglycemic Agents 0
Insulin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

443-448

Informations de copyright

Copyright © 2020 AACE. Published by Elsevier Inc. All rights reserved.

Auteurs

Ben Atkinson (B)

School of Public Health, Department of Health Services, University of Washington, Seattle, Washington.

Dawn Corl (D)

Department of Clinical Education, School of Nursing, University of Washington, Seattle, Washington.

Ronald Pergamit (R)

Department of Quality Improvement, University of Washington, Seattle, Washington.

Kathryn W Weaver (KW)

Division of Endocrinology, Metabolism and Nutrition, Department of Medicine, University of Washington, Seattle, Washington.

Tracy Tylee (T)

Division of Endocrinology, Metabolism and Nutrition, Department of Medicine, University of Washington, Seattle, Washington.

Brent E Wisse (BE)

Division of Endocrinology, Metabolism and Nutrition, Department of Medicine, University of Washington, Seattle, Washington. Electronic address: bewisse@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH